{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T13:06:35Z","timestamp":1773234395125,"version":"3.50.1"},"reference-count":27,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[1983,10,1]],"date-time":"1983-10-01T00:00:00Z","timestamp":433814400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[1983,10,1]],"date-time":"1983-10-01T00:00:00Z","timestamp":433814400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ard.eular.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of the Rheumatic Diseases"],"published-print":{"date-parts":[[1983,10]]},"DOI":"10.1136\/ard.42.5.500","type":"journal-article","created":{"date-parts":[[2008,7,28]],"date-time":"2008-07-28T23:49:46Z","timestamp":1217288986000},"page":"500-504","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":32,"title":["Penicillamine-induced myasthenia in rheumatoid arthritis: its clinical and genetic features."],"prefix":"10.1016","volume":"42","author":[{"given":"J.P","family":"Delamere","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S","family":"Jobson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.P","family":"Mackintosh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L","family":"Wells","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.W","family":"Walton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"ref_1","first-page":"114","article-title":"Myasthenia associated with D-peniciliamine therapy","volume-title":"rheumatoid arthritis. Proc R Soc Med","volume":"70","author":"C, Bucknall R.","year":"1977","unstructured":"Bucknall R C. Myasthenia associated with D-peniciliamine therapy in rheumatoid arthritis. Proc R Soc Med 1977; 70 (suppl 3): 114-7."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1136\/bmj.2.5973.726-a","article-title":"Myasthenia syndrome during penicillamine treatment","volume":"B:","author":"Czlonkowska, A.","year":"1975","unstructured":"Czlonkowska A. Myasthenia syndrome during penicillamine treatment. Br Med J 1975; B: 726-7.","journal-title":"Br Med J"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/0002-9343(77)90153-X","article-title":"Penicillamine-associated myasthenia gravis, antiacetylcholine receptor and antistriational antibodies","volume":"63","author":"L, Masters C.; L, Dawkins R.; J, Zilko P.","year":"1977","unstructured":"Masters C L, Dawkins R L, Zilko P J, et al. Penicillamine-associated myasthenia gravis, antiacetylcholine receptor and antistriational antibodies. Am J Med 1977; 63: 689-94.","journal-title":"Am J Med"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1002\/art.1780230414","article-title":"Peniciliamine-induced myasthenia gravis in progressive systemic sclerosis","volume":"23","author":"F, Toffes C.; C, Griggs R.; J, Baum; S, Penn A.","year":"1980","unstructured":"Toffes C F, Griggs R C, Baum J, Penn A S. Peniciliamine-induced myasthenia gravis in progressive systemic sclerosis. Arthritis Rheum 1980; 23: 505-8.","journal-title":"Arthritis Rheum"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1056\/NEJM198202113060602","article-title":"A prospective trial of D-penicillamine in primary biliary cirrhosis","volume":"306","author":"S, Matloff D.; E, Alpert; H, Resnick R.; M, Koplan M.","year":"1982","unstructured":"Matloff D S, Alpert E, Resnick R H, Koplan M M. A prospective trial of D-penicillamine in primary biliary cirrhosis. N Engl J Med 1982; 306: 319-26.","journal-title":"N Engl J Med"},{"key":"ref_6","first-page":"169","volume":"7","author":"L, Dawkins R.; J, Garlepp M.; L, McDonald B.","year":"1981","unstructured":"Dawkins R L, Garlepp M J, McDonald B L, et at. Myasthenia gravis and D-peniciflamine. J Rhewnatol 1981; suppl 7: 169-74.","journal-title":"et at. Myasthenia gravis and D-peniciflamine. J Rhewnatol"},{"key":"ref_7","first-page":"1107","article-title":"Hydralazine-induced systemic lupus erythematosus: influence of HLA-Dr and sex on susceptibility","volume":"i:","author":"R, Batchelor J.; I, Welsh K.; M, Tinoco R.","year":"1980","unstructured":"Batchelor J R, Welsh K I, Tinoco R M, et al. Hydralazine-induced systemic lupus erythematosus: influence of HLA-Dr and sex on susceptibility. Lancet 1980; i: 1107-9.","journal-title":"Lancet"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1056\/NEJM198008073030602","article-title":"HLA-Dr antigens and toxic reaction to sodium aurothiomalate and D-penicillamine in patients with rheumatoid arthritis","volume":"303","author":"H, Wooley P.; J, Griffin; S, Panayi G.","year":"1980","unstructured":"Wooley P H, Griffin J, Panayi G S, et al. HLA-Dr antigens and toxic reaction to sodium aurothiomalate and D-penicillamine in patients with rheumatoid arthritis. N Engl J Med 1980; 303: 300-2.","journal-title":"N Engl J Med"},{"key":"ref_9","first-page":"131","article-title":"gravis, autoantibodies and HLA antigens","volume":"1974","author":"W, Feltkamp T.E.","unstructured":"Feltkamp T E W, Van Den Berg-Loonen P M, Nijenhuis L E, et al. Myasthenia gravis, autoantibodies and HLA antigens. Br Mcd J 1974;: 131-3.","journal-title":"Br Mcd J"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/S0140-6736(73)91130-6","article-title":"Immune response genes in myasthenia gravis","volume":"1","author":"Behan P 0, Simpson J A, Dick H","year":"1973","unstructured":"Behan P 0, Simpson J A, Dick H. Immune response genes in myasthenia gravis. Lancet 1973; 1: 1033.","journal-title":"Lancet"},{"key":"ref_11","first-page":"224","article-title":"Myasthenia gravis","author":"L, Dawkins R.","year":"1977","unstructured":"Dawkins R L. Myasthenia gravis. In: Bodmer W F, Batchelor J R, Bodmer J G, Festenstein H, Morris P J, eds. Histocompatibility testing 1977. Copenhagen: Munksgaard, 1978: 224-9."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1212\/WNL.28.3.266","article-title":"Function of circulating antibody to acetylcholine receptor in myasthenia gravis: investigation by plasma exchange","volume":"28","author":"Newson-Davis, J.; J, Pinching A.; Vincent, A.; G, Wilson S.","year":"1978","unstructured":"Newson-Davis J, Pinching A J, Vincent A, Wilson S G. Function of circulating antibody to acetylcholine receptor in myasthenia gravis: investigation by plasma exchange. Neurology 1978; 28: 266-72.","journal-title":"Neurology"},{"key":"ref_13","first-page":"34","article-title":"Ia serology","author":"G, Bodmer J.; P, Pickboume; S, Richards","year":"1977","unstructured":"Bodmer J G, Pickboume P, Richards S. Ia serology. In: Bodmer W F, Batchelor J R, Bodmer J G, Festenstein H, Morris P J, ed. Histocompadbiity testing 1977. Copenhagen: Munksgaard 1978: 34-84."},{"key":"ref_14","first-page":"3576","article-title":"Inherited structural polymorphism of the fourth component","volume-title":"of human complement. Proc Natl Acad Sci USA","volume":"77","author":"L, Awdeh Z.; A, Alper C.","year":"1980","unstructured":"Awdeh Z L, Alper C A. Inherited structural polymorphism of the fourth component of human complement. Proc Natl Acad Sci USA 1980; 77: 3576-80."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1084\/jem.135.1.68","article-title":"Genetic polymorphism in human glycine-rich beta-glycoprotein","volume":"135","author":"A, Alper C.; T, Boenisch; L, Watson","year":"1972","unstructured":"Alper C A, Boenisch T, Watson L. Genetic polymorphism in human glycine-rich beta-glycoprotein. J Exp Med 1972; 135: 68-80.","journal-title":"J Exp Med"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1002\/eji.1830061216","article-title":"Mapping of the HLA locus controlling C2 structural variants and linkage disequilibrium between alleles C2 and Bw15","volume":"6","author":"Meo, T.; Atkinson, J.; Bemoco, M.; Bernoco, D.; CeppeUlini, R.","year":"1976","unstructured":"Meo T, Atkinson J, Bemoco M, Bernoco D, CeppeUlini R. Mapping of the HLA locus controlling C2 structural variants and linkage disequilibrium between alleles C2 and Bw15. Eur J Immunol 1976; 6: 916-9.","journal-title":"Eur J Immunol"},{"key":"ref_17","first-page":"91","article-title":"Myasthenia associated with D-penicillamine therapy in rheumatoid arthritis","volume":"28","author":"C, Bucknall R.; G, Balint; L, Dawkins R.","year":"1979","unstructured":"Bucknall R C, Balint G, Dawkins R L. Myasthenia associated with D-penicillamine therapy in rheumatoid arthritis. Scand J Rheumatol 1979; suppl 28: 91-3.","journal-title":"Scand J Rheumatol"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"578","DOI":"10.7326\/0003-4819-87-5-578","article-title":"D-penicillamine induced myasthenia gravis in rheumatoid arthritis","volume":"87","author":"A, Gordan R.; W, Burnside J.","year":"1977","unstructured":"Gordan R A, Burnside J W. D-penicillamine induced myasthenia gravis in rheumatoid arthritis. Ann Intern Med 1977; 87: 578-9.","journal-title":"Ann Intern Med"},{"key":"ref_19","first-page":"1254","article-title":"Anti-acetylcholine receptor antibodies in D-penicillamine associated myasthenia gravis","volume":"1","author":"Vincent, A.; Newson-Davis, J.; Martin, V.","year":"1978","unstructured":"Vincent A, Newson-Davis J, Martin V. Anti-acetylcholine receptor antibodies in D-penicillamine associated myasthenia gravis. Lancet 1978; 1: 1254.","journal-title":"Lancet"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1822","DOI":"10.1001\/jama.1980.03310160038022","article-title":"Myasthenia gravis and penicillamine therapy of rheumatoid arthritis","volume":"244","author":"Bocanegra, T.; R, Espinoza L.; B, Vasey F.; Germain, B.F.","year":"1980","unstructured":"Bocanegra T, Espinoza L R, Vasey F B, Germain BF. Myasthenia gravis and penicillamine therapy of rheumatoid arthritis. JAMA 1980; 244: 1822-3.","journal-title":"JAMA"},{"key":"ref_21","first-page":"730","article-title":"HLA-DRw 4 and rheumatoid arthritis","volume":"i:","author":"S, Panayi G.; P, Wooley; R, Batchelor J.","year":"1979","unstructured":"Panayi G S, Wooley P, Batchelor J R. HLA-DRw 4 and rheumatoid arthritis. Lancet 1979; i: 730.","journal-title":"Lancet"},{"key":"ref_22","first-page":"1326","article-title":"Genetic basis of rheumatoid disease: HLA antigens, disease manifestations, and toxic reactions to drugs","volume":"I:","author":"S, Panayi G.; P, Wooley; R, Batchelor J.","year":"1978","unstructured":"Panayi G S, Wooley P, Batchelor J R. Genetic basis of rheumatoid disease: HLA antigens, disease manifestations, and toxic reactions to drugs. Br Med J 1978; I: 1326-8.","journal-title":"Br Med J"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1136\/bmj.283.6302.1287","article-title":"DR antigens and rheumatoid arthritis: a study of two populations","volume":"283","author":"C, Woodrow J.; E, Nichol F.; G, Zaphiropoulos","year":"1981","unstructured":"Woodrow J C, Nichol F E, Zaphiropoulos G. DR antigens and rheumatoid arthritis: a study of two populations. Br Med J 1981; 283: 1287-8.","journal-title":"Br Med J"},{"issue":"8","key":"ref_24","first-page":"303","article-title":"Plasma exchange therapy for severe penicillamine-induced myasthenia gravis","volume":"1981","author":"E, Lang A.; G, Humphrey J.; A, Gordon D.","unstructured":"Lang A E, Humphrey J G, Gordon D A. Plasma exchange therapy for severe penicillamine-induced myasthenia gravis. J Rheumatol 1981: 8: 303-7.","journal-title":"J Rheumatol"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1212\/WNL.29.4.528-a","article-title":"HLA antigens in penicillamine-induced myasthenia gravis","volume":"29","author":"Keesey, J.; Novom, S.","year":"1979","unstructured":"Keesey J, Novom S. HLA antigens in penicillamine-induced myasthenia gravis. Neurology 1979; 29t 528-9.","journal-title":"Neurology"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1038\/268527a0","article-title":"Very close linkage between HLA-B and Bf inferred from ailelic association","volume":"266","author":"Arnason, A.; Larsen, B.; H, Marshall W.","year":"1977","unstructured":"Arnason A, Larsen B, Marshall W H, et al. Very close linkage between HLA-B and Bf inferred from ailelic association. Nature 1977; 266: 527-8.","journal-title":"Nature"},{"key":"ref_27","first-page":"65","article-title":"HLA antigens and adverse reactions to anti-rheumatic drugs","volume-title":"Modulation of autoimmunity and disease. The peniciUamine experience","author":"S, Panayi G.","year":"1981","unstructured":"Panayi G S. HLA antigens and adverse reactions to anti-rheumatic drugs. In: Maini R N, Berry H, eds. Modulation of autoimmunity and disease. The peniciUamine experience. Eastbourne: Praeger, 1981: 65-9."}],"container-title":["Annals of the Rheumatic Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496724134619?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496724134619?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/ard.42.5.500","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,21]],"date-time":"2025-01-21T08:14:32Z","timestamp":1737447272000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003496724134619"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1983,10]]},"references-count":27,"journal-issue":{"issue":"5","published-print":{"date-parts":[[1983,10]]}},"alternative-id":["S0003496724134619"],"URL":"https:\/\/doi.org\/10.1136\/ard.42.5.500","relation":{},"ISSN":["0003-4967"],"issn-type":[{"value":"0003-4967","type":"print"}],"subject":[],"published":{"date-parts":[[1983,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Penicillamine-induced myasthenia in rheumatoid arthritis: its clinical and genetic features.","name":"articletitle","label":"Article Title"},{"value":"Annals of the Rheumatic Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1136\/ard.42.5.500","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 1983 \u00a9 THE AUTHORS. Published by Elsevier B.V. on behalf of European Alliance of Associations for Rheumatology, EULAR. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}